Published January 1, 2021 | Version v1
Journal article Open

In silico analysis of FDA approved drugs against SARS-CoV-2 viral ORF3a protein

  • 1. Selcuk Univ, Fac Med, Konya, Turkey
  • 2. TUBITAK, Genet Engn & Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey

Description

Öz bulunamadı.

Files

bib-38fab155-ca4b-4cf8-8298-9d6137162b60.txt

Files (174 Bytes)

Name Size Download all
md5:ef79284243a45fe03f88eb874a7b6d31
174 Bytes Preview Download